Zai Lab

Zai Lab OCF/Debt

The Operating Cash Flow to Debt Ratio of Zai Lab (ZLAB) as of Oct 28, 2026 is -71.51 %. In the previous year, Operating Cash Flow to Debt Ratio was -153.74 % — a change of -53.49% (higher).

OCF/Debt

-71.51 %

YoY

-53.49%

Last updated:

Operating Cash Flow to Debt Ratio of Zai Lab is 2025 -71.51 % . Operating Cash Flow to Debt Ratio of Zai Lab was 2024 -153.74 % . It decreases by -53.49% higher compared to the previous year.

The Zai Lab OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
-2,677.41 USD
Jan 1, 2019
-1,768.46 USD
Jan 1, 2020
-4,150.12 USD
Jan 1, 2021
-9,266.59 USD
Jan 1, 2022
-5,214.78 USD
Jan 1, 2023
-2,789.67 USD
Jan 1, 2024
-153.74 USD
Jan 1, 2025
-71.51 USD
The Zai Lab OCF/Debt history
YEAROCF/DebtYoY
-71.51 %-53.49%
-153.74 %-94.49%
-2,789.67 %-46.50%
-5,214.78 %-43.72%
-9,266.59 %+123.29%
-4,150.12 %+134.67%
-1,768.46 %-33.95%
-2,677.41 %+197,941.66%
-1.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

Operating Cash Flow to Debt Ratio of Zai Lab is -71.51 % in 2025.

Operating Cash Flow to Debt Ratio of Zai Lab changed from -153.74 % to -71.51 %, representing a -53.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Zai Lab since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Zai Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Zai Lab

All Key Metrics — Zai Lab